Medical device company Zimmer Biomet (NYSE:ZBH) will be announcing earnings results this Tuesday before market open. Here’s what investors should know.
Zimmer Biomet (NYSE: ZBH) announced today that it received FDA 510(k) clearance for its G7 acetabular system for hip ...
Zimmer Biomet announced they are laying off workers in Warsaw and Worldwide locations.Warsaw is recognized as the "Orthopedic Capital of the World. But now one ...
Layoffs are underway at Warsaw-based orthopedic manufacturer Zimmer Biomet. Company officials say they are not disclosing the total number of employees affected, noting that most of the layoffs are ...
Evaluate the expected performance of Zimmer (ZBH) for the quarter ended December 2025, looking beyond the conventional Wall ...
Zimmer Biomet earns FDA clearance for the G7 Acetabular System, enabling U.S. commercialization of this advanced hip implant.
Zacks Investment Research on MSN
Zimmer Biomet (ZBH) earnings expected to grow: What to know ahead of next week's release
Zimmer Biomet (ZBH) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results ...
Musculoskeletal product breadth supports procedural demand Global healthcare footprint remains diversified Broader market ...
Zimmer Biomet Holdings, Inc (NYSE:ZBH) reported better-than-expected earnings for the first quarter on Monday. The company posted first-quarter adjusted EPS of $1.81, down from $1.94 a year ago, ...
Zimmer Biomet Holdings, Inc. has a definitive agreement to acquire all outstanding shares of the AI-driven orthopedic robotics company Monogram Technologies Inc., an equity deal valued at $177 million ...
Paragon 28, Inc. (NYSE:FNA) shares are trading higher premarket on Wednesday. On Tuesday, the company inked a deal to be acquired by Zimmer Biomet Holdings, Inc. (NYSE:ZBH) at around $1.1 billion in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results